miR-136 modulates TGF-β1-induced proliferation arrest by targeting PPP2R2A in keratinocytes

Dianbao Zhang1, Jing Wang2, Zhe Wang3

  • 1Department of Stem Cells and Regenerative Medicine, Key Laboratory of Cell Biology, Ministry of Public Health and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang 110001, China.

Insights

MicroRNA-136 (miR-136) levels decrease in keratinocytes treated with TGF-β1, impacting cell proliferation. Restoring miR-136 or silencing PPP2R2A counteracts this arrest, suggesting a role in wound healing.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Dermatology

Background:

  • Keratinocyte proliferation is essential for wound healing.
  • Dysregulation of microRNAs (miRNAs) is implicated in keratinocyte proliferation.
  • The precise molecular mechanisms underlying these processes require further elucidation.

Purpose of the Study:

  • To investigate the role of miR-136 in TGF-β1-induced keratinocyte proliferation arrest.
  • To identify the molecular targets and pathways involved in miR-136 regulation.
  • To explore the potential of miR-136 as a therapeutic target for skin wound healing.

Main Methods:

  • Treatment of HaCaT cells and normal human epidermal keratinocytes (NHEK) with TGF-β1.
  • Quantitative real-time PCR to measure miR-136 levels.
  • Cell proliferation assays and cell cycle analysis.
  • Transfection with miR-136 mimics or small interfering RNAs (siRNAs) targeting PPP2R2A.
  • Dual-luciferase reporter assays and Western blotting to validate PPP2R2A as a direct target of miR-136.

Main Results:

  • TGF-β1 treatment significantly decreased miR-136 levels in a Smad3-dependent manner.
  • Reintroduction of miR-136 or silencing of PPP2R2A counteracted TGF-β1-induced proliferation arrest in HaCaT cells.
  • PPP2R2A was confirmed as a direct target of miR-136.

Conclusions:

  • miR-136 plays a crucial role in regulating TGF-β1-induced proliferation arrest in keratinocytes.
  • The miR-136/PPP2R2A axis is a key pathway involved in keratinocyte proliferation.
  • Targeting miR-136 may offer a novel therapeutic strategy for enhancing skin wound healing.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K